The Food Safety and Standards Authority of India (FSSAI) has initiated legal action against Nestlé India by filing three adjudication cases over alleged regulatory non-compliance in its baby nutrition portfolio.
Following an examination of popular formulations including NAN Excella Pro Stage 1, Lactogen Pro 1, and Follow-up Formula across e-commerce platforms, the apex food safety regulator flagged unlawful promotional claims and substandard nutrient composition. While the statutory body highlighted direct violations of infant advertising bans and deficient biotin levels, Nestlé India maintained that its products remain fully compliant, scientifically backed, and previously vetted by an expert committee.
Scrutiny on Marketing Claims
The regulatory intervention zeroes in on aggressive promotional marketing alongside nutrient deficiencies.
The FSSAI observed that labels and digital listings for NAN Excella Pro Stage 1 promoted “5 HMOs” (Human Milk Oligosaccharides) and “Whey Protein”, whilst Lactogen Pro 1 highlighted that its whey protein was “easy to digest”. Authorities concluded that such branding breaches Regulation 4(2) of the Food Safety and Standards (Foods for Infant Nutrition) Regulations, 2020, which bars promotional assertions designed to enhance the commercial saleability of infant food, as well as Section 3 of the Infant Milk Substitutes (IMS) Act, 1992, which strictly forbids the promotion and advertising of infant milk substitutes. Furthermore, laboratory evaluation of a Nestlé Follow-up Formula revealed substandard biotin (Vitamin B7) levels—a finding subsequently confirmed upon re-analysis by a statutory referral laboratory.
Defending its portfolio, a Nestlé India spokesperson stated: “Our products are fully compliant with all the applicable regulations. The said products and their labels were approved by the expert committee of FSSAI. In response to the notice, we have again submitted our detailed response… regarding statements appearing on the label, which are factual in nature, and supported by scientific literature.”
Stricter Oversight
This legal intervention reflects a broader regulatory crackdown across India’s packaged food landscape, aimed at curbing deceptive wellness marketing and safeguarding infant welfare.
Paediatric experts and public health advocates have consistently advised that during the first six months of life, exclusive breastfeeding remains the gold standard, providing unmatched immunological and nutritional benefits that cannot be replicated by commercial milk substitutes. When supplemental nutrition becomes medically necessary, paediatricians advise parents to critically review statutory ingredient panels rather than relying on persuasive front-of-pack buzzwords like “brain development” or “easy digestion.”
The strict implementation of the IMS Act exists specifically to prevent corporate marketing from undermining breastfeeding practices or misleading vulnerable caregivers into perceiving formula milk as superior or indispensable.
The Logical Indian’s Perspective
A society’s moral integrity is reflected in how fiercely it safeguards its most vulnerable members—its children. When corporate balance sheets and aggressive sales pitches compromise nutritional transparency, trust between citizens and essential institutions breaks down.
We believe that true progress relies on empathy, ethical corporate responsibility, and unwavering regulatory vigilance. Multinational corporations must honour both the letter and the spirit of public health laws, ensuring commercial ambition never eclipses the well-being of infants. As conscious consumers and community members, we must champion honest dialogue, demand rigorous transparency from food manufacturers, and foster an ecosystem where the health of future generations takes precedence above all else. How can we, as a community of consumers and parents, hold packaged food brands accountable for ethical marketing, and what measures should regulators introduce to keep infant nutrition transparent?
Also Read: Karnataka Cabinet Recognises Tulu as Second Additional Administrative Language
